GAMBLING DISORDER: CASE REPORT AND REVIEW OF CLINICAL AND PSYCHOSOCIAL ASPECTS
DOI:
https://doi.org/10.56238/arev8n1-079Keywords:
Gambling Disorder, Multidisciplinary Treatment, Drug TherapyAbstract
Introduction: Gambling is defined as activities involving the wagering of money in an attempt to predict the outcome of a future event, the outcome of which is largely independent of the bettor's actions. Among the most popular forms of this practice are casino games, lotteries, and Internet gambling, including poker and sports betting. Gambling disorder is the term adopted by the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) to describe a persistent and recurrent pattern of gambling behavior associated with significant distress or substantial impairment in various areas of life. The lifetime prevalence is 1%, making it the third most common behavior after tobacco and alcohol. Treatment is complex, with an emphasis on psychosocial interventions. Objective: To report a case of a patient referred to the psychiatry service by primary care in her city of origin due to dysfunctional behavior related to gambling on various digital platforms and to discuss the therapeutic interventions adopted, considering the main clinical, social, and psychopathological aspects associated with the condition and discussing the difficulties faced in the multidisciplinary management of gambling disorder. Methodology: This is a clinical case report, complemented by a narrative review of the literature, based on a retrospective analysis of the electronic medical records of a patient treated at the Psychiatry Outpatient Clinic of the Base Hospital of the São José do Rio Preto Medical School, linked to the Department of Neurological Sciences, Psychiatry, and Medical Psychology of FAMERP. Results: A 24-year-old female patient with persistent and maladaptive online gambling behavior, associated with significant financial, social, and emotional losses. Initial treatment included psychotropic drugs (fluoxetine, naltrexone, valproate, and risperidone), blocking accounts on digital platforms, and referral for psychotherapy, resulting in partial improvement. However, the patient did not have effective access to psychotherapy during follow-up, which contributed to relapse, discontinuation of follow-up, and maintenance of functional impairments. Conclusion: The management of gambling disorder requires a multidisciplinary approach, combining psychosocial and pharmacological interventions and ongoing support, with attention to psychiatric comorbidities. The difficulty of accessing specialized therapies, the high relapse rate, and the psychosocial impacts of gambling behavior highlight the need for more effective public policies, in addition to individualized therapeutic strategies to promote comprehensive rehabilitation and prevent new episodes.
Downloads
References
AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and statistical manual of mental disorders. 3. ed. Washington, DC: American Psychiatric Association, 1980.
AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and statistical manual of mental disorders. 4. ed. Washington, DC: American Psychiatric Association, 1994.
AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and statistical manual of mental disorders. 5. ed. Washington, DC: American Psychiatric Association, 2013. Disponível em: https://doi.org/10.1176/appi.books.9780890425596. Acesso em: 6 set. 2025.
BLACK, D. W.; ARNDT, S.; CORYELL, W. H.; ALLEN, J. Bupropion in the treatment of pathological gambling: a randomized, placebo-controlled trial. Journal of Clinical Psychopharmacology, v. 27, n. 2, p. 143–150, 2007. Disponível em: https://doi.org/10.1097/JCP.0b013e31803164e5.
BLANCO, C.; HASIN, D. S.; PETRY, N. M.; STINSON, F. S.; GRANT, B. F. Sex differences in subclinical and DSM-IV pathological gambling: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychological Medicine, v. 36, n. 7, p. 943–953, 2006. Disponível em: https://doi.org/10.1017/S0033291706007588.
BLANCO, C.; PETRY, N. M.; GRANT, J. E.; POTENZA, M. N. Pharmacological treatment of pathological gambling: a review. Journal of Clinical Psychiatry, v. 63, suppl. 4, p. 15–23, 2002.
DE BRITO, A. M.; DE ALMEIDA PINTO, M. G.; BRONSTEIN, G.; BUCHPIGUEL, C. A.; TAVARES, H.; NETO, F. L. Topiramate combined with cognitive restructuring for the treatment of gambling disorder: a two-center, randomized, double-blind clinical trial. Journal of Gambling Studies, v. 33, n. 1, p. 249–263, 2017. Disponível em: https://doi.org/10.1007/s10899-016-9613-2.
FEBRABAN. Estudo nacional sobre bets: percepções e atitudes sobre apostas esportivas online. Brasília: Federação Brasileira de Bancos, out. 2024.
GAINSBURY, S. Internet gambling: current research findings and implications. New York: Springer Science & Business Media, 2012.
GRANT, J. E.; BREWER, J. A.; POTENZA, M. N. The neurobiology of substance and behavioral addictions. CNS Spectrums, v. 11, n. 12, p. 924–930, 2006. Disponível em: https://doi.org/10.1017/S1092852900016430.
GRANT, J. E.; KIM, S. W.; HARTMAN, B. K. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. Journal of Clinical Psychiatry, v. 69, n. 5, p. 783–789, 2008. Disponível em: https://doi.org/10.4088/jcp.v69n0512.
GRANT, J. E.; POTENZA, M. N.; WEINSTEIN, A.; GORELICK, D. A. Introduction to behavioral addictions. American Journal of Drug and Alcohol Abuse, v. 36, n. 5, p. 233–241, 2010. Disponível em: https://doi.org/10.3109/00952990.2010.491884.
GRANT, J. E.; SCHREIBER, L. R. N.; ODLAUG, B. L. Phenomenology and treatment of behavioural addictions. The Canadian Journal of Psychiatry, v. 58, n. 5, p. 252–259, 2013. Disponível em: https://doi.org/10.1177/070674371305800502.
HALLER, E.; HINTERHUBER, H. Treatment of pathological gambling with carbamazepine. American Journal of Psychiatry, v. 151, n. 3, p. 491, 1994. Disponível em: https://doi.org/10.1176/ajp.151.3.491.
HOLLANDER, E.; DECARIA, C.; FINKELL, J. N.; BEGAZ, T.; WONG, C. M.; CARTWRIGHT, C. A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biological Psychiatry, v. 47, n. 9, p. 813–817, 2000. Disponível em: https://doi.org/10.1016/S0006-3223(99)00383-4.
INSTITUTO LOCOMOTIVA. Perfil dos apostadores no Brasil. São Paulo: Instituto Locomotiva, ago. 2024. Disponível em: https://www.institutolocomotiva.org.br. Acesso em: 6 set. 2025.
KOOB, G. F. Neurobiology of addiction: toward the development of new therapies. Annals of the New York Academy of Sciences, v. 909, n. 1, p. 170–185, 2000. Disponível em: https://doi.org/10.1111/j.1749-6632.2000.tb06680.x.
MARAZZITI, D.; BARONI, S.; PICCHETTI, M.; PICCINNI, A.; DELL’OSSO, L. Pharmacological treatment of pathological gambling: a review of the literature. Current Pharmaceutical Design, v. 14, n. 25, p. 2732–2740, 2008. Disponível em: https://doi.org/10.2174/138161208786404053.
ORGANIZAÇÃO MUNDIAL DA SAÚDE. Classificação estatística internacional de doenças e problemas relacionados à saúde. 10. ed. Brasília: Ministério da Saúde, 1993.
POTENZA, M. N.; BALODIS, I. M.; DEREVENSKY, J.; GRANT, J. E.; PETRY, N. M.; BLANCO, C. et al. Gambling disorder. Nature Reviews Disease Primers, v. 5, art. 51, 2019. Disponível em: https://doi.org/10.1038/s41572-019-0099-7.
POTENZA, M. N.; STEINBERG, M. A.; MCLAUGHLIN, S. D.; FULDA, K. G.; ROUNSAVILLE, B. J.; O’MALLEY, S. S. Gender-related differences in the characteristics of problem gamblers using a gambling helpline. American Journal of Psychiatry, v. 158, n. 9, p. 1500–1505, 2001. Disponível em: https://doi.org/10.1176/appi.ajp.158.9.1500.
SHAFFER, H. J.; KIDMAN, R. Shifting perspectives on gambling and addiction. Journal of Gambling Studies, v. 19, n. 1, p. 1–6, 2003. Disponível em: https://doi.org/10.1023/A:1021241724333.
TAVARES, H.; CARNEIRO, E.; SANCHES, S.; PINSKY, I.; CAETANO, R.; ZALESKI, M. et al. Gambling in Brazil: lifetime prevalences and socio-demographic correlates. Psychiatry Research, v. 180, n. 1, p. 35–41, 2010. Disponível em: https://doi.org/10.1016/j.psychres.2009.08.013.
TAVARES, H.; ZILBERMAN, M. L.; HODGINS, D. C.; EL-GUEBALY, N. Comparison of craving between pathological gamblers and alcoholics. Alcoholism: Clinical and Experimental Research, v. 29, n. 8, p. 1427–1431, 2005. Disponível em: https://doi.org/10.1097/01.ALC.0000175078.05184.57.
VICTORRI-VIGNEAU, C.; SPIERS, A.; CAILLET, P.; CHALLET-BOUJU, G.; GRALL-BRONNEC, M. Opioid antagonists for pharmacological treatment of gambling disorder: are they relevant? Current Neuropharmacology, v. 16, n. 10, p. 1418–1432, 2018. Disponível em: https://doi.org/10.2174/1570159X16666180309111229.
WILLIAMS, W. A.; POTENZA, M. N. Neurobiologia dos transtornos do controle dos impulsos. Brazilian Journal of Psychiatry, v. 30, suppl. 1, p. S24–S30, 2008. Disponível em: https://doi.org/10.1590/S1516-44462008005000003.
WORLD HEALTH ORGANIZATION. International classification of diseases for mortality and morbidity statistics. 11. ed. Geneva: World Health Organization, 2019. Disponível em: https://icd.who.int/. Acesso em: 6 set. 2025.
